Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,603 | -1,623 | -576 | -323 | -1,812 |
| Depreciation Amortization | 314 | 274 | 119 | 40 | 216 |
| Accounts receivable | -2,358 | -1,515 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 404 | 143 | 334 | 310 | N/A |
| Other Working Capital | -1,984 | -1,374 | 325 | 299 | 764 |
| Other Operating Activity | 2,272 | 1,943 | -334 | -290 | 913 |
| Operating Cash Flow | $-3,955 | $-2,152 | $-132 | $36 | $81 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 142 | 142 | 102 | N/A | N/A |
| Common Stock Issued | 5,524 | 5,524 | N/A | N/A | N/A |
| Other Financing Activity | -532 | -390 | -42 | -89 | -425 |
| Financing Cash Flow | $5,134 | $5,276 | $60 | $-89 | $-425 |
| Beginning Cash Position | 93 | 93 | 93 | 93 | 437 |
| End Cash Position | 1,272 | 3,217 | 21 | 40 | 93 |
| Net Cash Flow | $1,179 | $3,124 | $-72 | $-53 | $-344 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,955 | -2,152 | -132 | 36 | 81 |
| Free Cash Flow | -3,955 | -2,152 | -132 | 36 | 81 |